Human tripartite motif 5α domains responsible for retrovirus restriction activity and specificity

被引:216
作者
Perez-Caballero, D
Hatziioannou, T
Yang, A
Cowan, S
Bieniasz, PD
机构
[1] Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA
[2] Rockefeller Univ, New York, NY 10016 USA
关键词
D O I
10.1128/JVI.79.14.8969-8978.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The tripartite motif 5 alpha protein (TRIM5 alpha) is one of several factors expressed by mammalian cells that inhibit retrovirus replication. Human TRIM5 alpha (huTRIM5 alpha) inhibits infection by N-tropic murine leukemia virus (N-MLV) but is inactive against human immunodeficiency virus type 1 (HIV-1). However, we show that replacement of a small segment in the carboxy-terminal B30.2/SPRY domain of huTRIM5a with its rhesus macaque counterpart (rhTRIM5 alpha) endows it with the ability to potently inhibit HIV-1 infection. The B30.2/ SPRY domain and an additional domain in huTRIM5 alpha, comprising the amino-terminal RING and B-box components of the TRIM motif, are required for N-MLV restriction activity, while the intervening coiled-coil domain is necessary and sufficient for huTRIM5 alpha multimerization. Truncated huTRIM5 alpha proteins that lack either or both the N-terminal RING/B-Box or the C-terminal B30.2/SPRY domain form heteromultimers with full-length huTRIM5 alpha and are dominant inhibitors of its N-MLV restricting activity, suggesting that homomultimerization of intact huTRIM5 alpha monomers is necessary for N-MLV restriction. However, localization in large cytoplasmic bodies is not required for inhibition of N-MLV by huTRIM5 alpha or for inhibition of HIV-1 by chimeric or rhTRIM5 alpha.
引用
收藏
页码:8969 / 8978
页数:10
相关论文
共 32 条
  • [1] Positional cloning of the mouse retrovirus restriction gene Fv1
    Best, S
    LeTissier, P
    Towers, G
    Stoye, JP
    [J]. NATURE, 1996, 382 (6594) : 826 - 829
  • [2] Intrinsic immunity: a front-line defense against viral attack
    Bieniasz, PD
    [J]. NATURE IMMUNOLOGY, 2004, 5 (11) : 1109 - 1115
  • [3] Identification of the regions of Fv1 necessary for murine leukemia virus restriction
    Bishop, KN
    Bock, M
    Towers, G
    Stoye, JP
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (11) : 5182 - 5188
  • [4] Use of a transient assay for studying the genetic determinants of Fv1 restriction
    Bock, M
    Bishop, KN
    Towers, G
    Stoye, JP
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (16) : 7422 - 7430
  • [5] GENETIC-EVIDENCE THAT THE TAT PROTEINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 CAN MULTIMERIZE IN THE EUKARYOTIC CELL-NUCLEUS
    BOGERD, HP
    FRIDELL, RA
    BLAIR, WS
    CULLEN, BR
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (08) : 5030 - 5034
  • [6] Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
    Cowan, S
    Hatziioannou, T
    Cunningham, T
    Muesing, MA
    Gottlinger, HG
    Bieniasz, PD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) : 11914 - 11919
  • [7] Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells
    Forshey, BM
    Shi, J
    Aiken, C
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (02) : 869 - 875
  • [8] Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein
    Gao, GX
    Guo, XM
    Goff, SP
    [J]. SCIENCE, 2002, 297 (5587) : 1703 - 1706
  • [9] Genetic control of retrovirus susceptibility in mammalian cells
    Goff, SP
    [J]. ANNUAL REVIEW OF GENETICS, 2004, 38 : 61 - 85
  • [10] Operating under a gag order: A block against incoming virus by the Fv1 gene
    Goff, SP
    [J]. CELL, 1996, 86 (05) : 691 - 693